EMNJ:XETRA:XETRA-iShares MSCI Japan ESG Enhanced UCITS ETF USD Inc (EUR)

ETF | Others |

Last Closing

USD 5.831

Change

0.00 (0.00)%

Market Cap

USD 1.92B

Volume

2.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.55 (-1.07%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.18 (-1.06%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.34 (-1.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.31 (-1.11%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.36 (-1.48%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-0.88 (-0.60%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

-0.52 (-1.17%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.59 (-1.16%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-3.94 (-0.73%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.26 (-1.15%)

USD 79.79B

ETFs Containing EMNJ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.44% 56% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.44% 56% F 57% F
Trailing 12 Months  
Capital Gain 10.71% 52% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.71% 51% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.72% 52% F 51% F
Dividend Return 4.72% 51% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.71% 53% F 62% D
Risk Adjusted Return 40.31% 51% F 54% F
Market Capitalization 1.92B 87% B+ 78% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike